Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug-Receptor Interactions01:29

Drug-Receptor Interactions

5.3K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.3K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.0K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.0K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

3.0K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
3.0K
Factors Affecting Protein-Drug Binding: Drug Interactions01:23

Factors Affecting Protein-Drug Binding: Drug Interactions

173
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
173
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

267
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
267
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

79
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
79

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Siderophore-Porphyrin conjugates for bacteria-selective antimicrobial photodynamic therapy.

Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents·2026
Same author

Landscape of regulatory clinical investigations status of traditional and digital medical devices in the Republic of Korea (2003-mid 2024).

NPJ digital medicine·2026
Same author

UK Biobank whole-genome sequencing reveals robust contributions of rare variants to complex-trait heritability.

Genome biology·2026
Same author

Dosimetric characterization of CdZnTe radiation detectors under electron-beam irradiation.

PloS one·2026
Same author

Chiral phonon-mediated superconductivity in alkali-doped fullerides: a unified framework connecting molecular superconductors to two-dimensional chiral superconductivity.

Journal of physics. Condensed matter : an Institute of Physics journal·2026
Same author

Noncanonical Folding of Peptoid Oligomers: Formation of a Closed Conformation in Nonpolar Solvent.

Organic letters·2026

相关实验视频

Updated: Jul 12, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K

PRID:使用RWR用于药物之间的相互作用的预测模型.

Jiwon Seo1, Hyein Jung1, Younhee Ko1

  • 1Division of Biomedical Engineering, Hankuk University of Foreign Studies, Yongin 17035, Gyeonggi-do, Republic of Korea.

Pharmaceutics
|October 28, 2023
PubMed
概括

这项研究介绍了PRID,这是一种深度学习模型,使用化学结构和蛋白质相互作用来预测药物相互作用 (DDI). PRID有效地识别了已知和潜在的DDI,提高了患者的安全.

科学领域:

  • 药理学 药理学是指药理学的学科.
  • 计算生物学 计算生物学
  • 生物信息学是一种生物信息学.

背景情况:

  • 药物相互作用 (DDI) 可以引起意想不到的药理学效应,使多药学复杂化.
  • 目前的DDI鉴定依赖于临床经验,缺乏安全联合处方的标准化数据库.
  • 现有的DDI预测计算方法由于功能可用性不完整和无法捕捉复杂的病理机制而存在局限性.

研究的目的:

  • 开发一种新的深度学习模型,用于预测药物相互作用 (DDI).
  • 整合化学结构相似性和蛋白质-蛋白质相互作用 (PPI) 数据,以提高DDI预测.
  • 通过准确识别潜在的DDI来改善患者安全和治疗策略.

主要方法:

  • 开发了一个深度学习模型,PRID,利用化学结构相似性和药物结合蛋白 (CTET) 信息.
  • 随机步行与重启 (RWR) 算法用于在PPI网络 (STRING数据库) 中传播CTET蛋白.
  • 这种方法结合了CTET蛋白和与疾病相关的基因之间的隐藏生物机制.

主要成果:

  • PRID模型成功预测了已知的药物相互作用,包括涉及药物的药物相互作用.
  • CTET蛋白的RWR传播有效地捕获了与DDI相关的间接共同调节的生物机制.
关键词:
在RWR中使用RWR.深度学习是一种深度学习.药物 药物相互作用

更多相关视频

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.6K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K

相关实验视频

Last Updated: Jul 12, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.6K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K
  • 该研究证明了PRID在预测已知和新药组合方面的有效性.
  • 结论:

    • 通过整合各种生物和化学数据,PRID提供了一种可靠的方法来预测药物相互作用.
    • 该模型揭示隐藏的生物机制的能力增强了对DDI因果关系的理解.
    • PRID有可能识别新的DDI并指导更安全的多药实践.